Lv1
40 积分 2025-09-24 加入
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial
24天前
已完结
Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis
24天前
已完结
Refractive status and retinal morphology in children with a history of intravitreal ranibizumab for retinopathy of prematurity
24天前
已完结
Corneal aberrations and anterior segment parameters in preterm children with or without a history of retinopathy of prematurity
24天前
已完结
Association of retinopathy of prematurity with early refractive development in mid-preterm infants
24天前
已完结
Identification of clinical factors associated with timing and duration of spontaneous regression of retinopathy of prematurity not requiring treatment
27天前
已完结
Optimised multivariable prediction model to predict treatment requirement in preterm infants with retinopathy of prematurity
1个月前
已完结
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence
3个月前
已完结
Association Between Social Determinants of Health and Retinopathy of Prematurity Outcomes
4个月前
已完结
The Incidence and Timing of Treatment-Requiring Retinopathy of Prematurity in Nanopremature and Micropremature Infants in the United States
4个月前
已关闭
皖公网安备34019202002308
